Equity Analysis /
United States of America

US : Antares Pharma, Inc. - ATRS | Weekly Rx Metrics: XYOSTED TRxs Still Tracking Strong, Epi Demand Remains Heightened

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    9 November 2021
    Published by